ArticleTranslational oncology2019

Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer.

Wei Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.